Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Non-Current Debt (2018 - 2026)

Rockwell Medical filings provide 10 years of Non-Current Debt readings, the most recent being $8.8 million for Q4 2025.

  • On a quarterly basis, Non-Current Debt rose 4.18% to $8.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.8 million, a 4.18% increase, with the full-year FY2025 number at $8.8 million, up 4.18% from a year prior.
  • Non-Current Debt hit $8.8 million in Q4 2025 for Rockwell Medical, up from $8.7 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $21.0 million in Q1 2021 to a low of $3.3 million in Q3 2023.
  • Median Non-Current Debt over the past 5 years was $8.6 million (2025), compared with a mean of $9.4 million.
  • Biggest five-year swings in Non-Current Debt: plummeted 62.83% in 2023 and later surged 151.67% in 2024.
  • Rockwell Medical's Non-Current Debt stood at $13.2 million in 2021, then tumbled by 42.7% to $7.6 million in 2022, then increased by 9.77% to $8.3 million in 2023, then rose by 2.16% to $8.5 million in 2024, then rose by 4.18% to $8.8 million in 2025.
  • The last three reported values for Non-Current Debt were $8.8 million (Q4 2025), $8.7 million (Q3 2025), and $8.6 million (Q2 2025) per Business Quant data.